ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Merus NV

Merus NV (2GH)

42.80
0.599999
( 1.42% )
Updated: 18:04:57
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
42.80
Bid
42.00
Offer
42.80
Volume
1
42.80 Day's Range 42.80
21.40 52 Week Range 58.50
Previous Close
42.20
Open
42.80
Last Trade
1
@
42.799999
Last Trade Time
18:04:57
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC Studie mit Petosemtamab in Kombination mit Pembrolizumab bei 1L...

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m...

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.200001-6.95652391304464742.79999924844.22983871DE
4-8.700001-16.893205825251.551.540.412544.72627361DE
12-2.400001-5.3097367256645.251.540.412747.17167127DE
26-6.200001-12.65306326534957.540.415948.54794972DE
5220.79999994.545452258.521.39999917544.36210739DE
15618.99999979.831928571423.858.51916742.00023485DE
26018.99999979.831928571423.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
9SBSOL Global Investments Corp
0.496 €
(106.67%)
402.21k
1UR1Bee Vectoring Technologies International Inc
0.0075 €
(50.00%)
15k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
3.45k
GSPComstock Inc
0.49 €
(25.64%)
17.5k
A28AAffimed NV
2.74 €
(24.55%)
8.01k
Y7GBioAge Labs Inc
6.20 €
(-67.37%)
400
LK1Lake Resources
0.0161 €
(-42.09%)
2k
NJF1Grid Metals Corp
0.016 €
(-37.25%)
2k
47GAGo Metals Corp
0.0202 €
(-36.48%)
2.2k
V44Tearlach Resources Limited
0.01 €
(-34.64%)
350
AXIAtos SE
0.0029 €
(3.57%)
178.56M
PF8European Lithium Limited
0.0278 €
(-12.03%)
791.3k
SGJHSinopec Shanghai Petrochemical Co Ltd
0.145 €
(3.72%)
701.5k
9SBSOL Global Investments Corp
0.496 €
(106.67%)
402.21k
3CPXiaomi Corporation
3.7395 €
(3.62%)
323.33k

Discussion

View Full Feed
RealDutch RealDutch 3 minutes ago
I JUST HOPE YOU RECEIVED YOUR MONEY WHICH WAS SUPPOSED TO BE CREDITED TO YOU ON 6TH DECEMBER 2024 PDT/PST?

You are not expecting any answers from me. So I don't have to answer it.
ITUP
RealDutch RealDutch 7 minutes ago
Reread what I said.

With that kind of attitude, you won't be getting any answers from the company, nor from me, nor from anyone else.

Where did I give the impression that I thought you were expecting an answer from me personally? Because I never gave that impression. It
ITUP
ducci1 ducci1 12 minutes ago
Charts; Scanning a few Sights---DIA 60 min W-- --Head & Shoulders Pattern Base B/Down 445-446---Duration 9 Days-----Also Nice GDX 60 min Falling Channel Triangle Base 35/36---B/Down or Support ??---Thought U Might Like !!
DIA GDX
RubyMartin RubyMartin 24 minutes ago
ERHE Web Site back up, but...... Latest news is from 2015.
ERHC Energy Inc. Issues November 2015 Shareholder Update
ERHE
BreakingNews1 BreakingNews1 25 minutes ago
$RDAR 💎 $700Million Projected in 2025

https://youtu.be/NcoOLB2eM94

#OTC #Stocks #StockMarket
RDAR
dalesio_98 dalesio_98 28 minutes ago
Next, anything to offer?

Good luck to All
along4zride along4zride 29 minutes ago
Doesn't look like the Calvary is coming anytime to save soon .(FNMA).
Even though more than $246 Billion has been paid back on loan unfortunately for hopeful investor the payments were interest only . Probably best to take a finance 101 course before investing in stocks in conservatorship.
FNMA
nowwhat2 nowwhat2 32 minutes ago
https://www.youtube.com/shorts/q60kpF0lcOw

Entro ayer a veinte y ocho

https://investorshub.advfn.com/uimage/uploads/2024/12/9/rxsrgsol_121212_8_4m_buy.jpg

https://bigcharts.marketwatch.com/advchart/frames/frames.asp?show=&insttype=Stock&symb=ca%3Asol&x
SOLCF
knrorrel knrorrel 34 minutes ago
back again......I was already wondering if they were gone forever .........

but at the slightest climb they are back again. ..........

very funny, but for me a good sign , that I am in the right place
imho
GVSI
nowwhat2 nowwhat2 42 minutes ago
https://www.youtube.com/shorts/wUl8AuW53UY
shajandr shajandr 51 minutes ago
Save this one also: IMO the pistol was nott a B&T Station Six - it was a standard-type 9mm semiauto - looks to be a hammerless design, at least no external hammer - so possibly a Glock 17 or 19 or similar striker-fired 9mm semiauto with an aftermarket threaded barrel and a homemade suppressor. A hom
devil dog 96 devil dog 96 55 minutes ago
Seems like you don't want to prove me wrong about ATMH having the best setup in the OTC for some reason. 😃 LMAO

" You're right... I don't think anybody could find bigger set up to lose their money quicker from any other OTC ...You sure can find them!
Registration of 12,
ATMH
MasterBlastr MasterBlastr 59 minutes ago
Alliance - NFL MNF Showdown - Captain Mode contest in lobby
Pick 6 players from the Dec. 9, Monday night CIN vs. DAL game, $50,000 salary cap. Your Captain receives 1.5x points but costs 1.5x the listed salary.
k9uwa k9uwa 1 hour ago
Anavex blarcamesine slows Brain atrophy. It SIGNIFICANTLY slows Cognitive decline. It is SAFE. Does not require any additional tests to be sure your not into Brain Bleed Mode. It is simple to administer. A simple Dry Pill. Have one before bedtime and get a GOOD NITES SLEEP. Anavex has now filed EMA
AVXL
Hoghead7 Hoghead7 1 hour ago
Just beginning. FCEL can do everything, from the Carbon Capture, heat and power, hydrogen production, and with different technologies.
FCEL
SSKILLZ1 SSKILLZ1 1 hour ago
Soto is gonna be excellent the first half of the contract in my opinion, the 2nd half of that contract won't be pretty however. He is only 26 next year not 36. But if he wins a mvp or two, and wins one or two championships over those first 7-9 years then the contract is worth it in my opinion. Plus
Zorax Zorax 1 hour ago
Problem is you're totally off topic on a dead stock board and don't know it.
HGLC
TommyJ7651 TommyJ7651 1 hour ago
Yeah, the 1B price tag to develop Springpole seems large BUT we have to keep in mind that this is peanuts for a bigger player such as Barrick, Agnico or Newmont or even a mid-tier producer. It's all just numbers really and companies just simply calculate if they think a mine will be profitable or no
FFMGF
Zorax Zorax 1 hour ago
Members were able to set their own background colors for years but I think the mobile app upgrades took that away some time ago.
TommyJ7651 TommyJ7651 1 hour ago
This is what makes me both sad and angry. Their remote communities have a zero chance of surviving the next decades if they don't get Springpole developed. There just won't be any new jobs, roads, infrastructure, schools, etc. if they don't get on board here. The next government will be leaning heav
FFMGF
Canna_Business Canna_Business 1 hour ago
https://www.reddit.com/r/WallStreetbetsELITE/comments/1ha0wxv/my_potfolio_is_very_long_and_green/
Canna_Business Canna_Business 1 hour ago
https://www.reddit.com/r/WallStreetbetsELITE/comments/1ha0wxv/my_potfolio_is_very_long_and_green/
SPY

Your Recent History

Delayed Upgrade Clock